Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy
Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, visual loss, and characteristic imaging pattern in brain MRI. The cause of PRES is not yet understood. We report a case of a 27-year-old woman that developed...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Case Reports in Oncological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2013/306983 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832555417738149888 |
|---|---|
| author | Luiz Carlos Porcello Marrone Bianca Fontana Marrone Tharick Ali Pascoal Lucas Porcello Schilling Ricardo Bernardi Soder Sheila Schuch Ferreira Giovani Gadonski Jaderson Costa da Costa |
| author_facet | Luiz Carlos Porcello Marrone Bianca Fontana Marrone Tharick Ali Pascoal Lucas Porcello Schilling Ricardo Bernardi Soder Sheila Schuch Ferreira Giovani Gadonski Jaderson Costa da Costa |
| author_sort | Luiz Carlos Porcello Marrone |
| collection | DOAJ |
| description | Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, visual loss, and characteristic imaging pattern in brain MRI. The cause of PRES is not yet understood. We report a case of a 27-year-old woman that developed PRES after the use of FOLFOX 5 (oxaliplatin/5-Fluoracil/Leucovorin) chemotherapy for a colorectal cancer. |
| format | Article |
| id | doaj-art-42aefd70481a471e9953bdac8e97be99 |
| institution | Kabale University |
| issn | 2090-6706 2090-6714 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Oncological Medicine |
| spelling | doaj-art-42aefd70481a471e9953bdac8e97be992025-02-03T05:48:15ZengWileyCase Reports in Oncological Medicine2090-67062090-67142013-01-01201310.1155/2013/306983306983Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX ChemotherapyLuiz Carlos Porcello Marrone0Bianca Fontana Marrone1Tharick Ali Pascoal2Lucas Porcello Schilling3Ricardo Bernardi Soder4Sheila Schuch Ferreira5Giovani Gadonski6Jaderson Costa da Costa7Hospital São Lucas/Instituto do Cérebro (Inscer), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, BrazilHospital São Lucas/Instituto do Cérebro (Inscer), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, BrazilHospital São Lucas/Instituto do Cérebro (Inscer), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, BrazilHospital São Lucas/Instituto do Cérebro (Inscer), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, BrazilHospital São Lucas/Instituto do Cérebro (Inscer), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, BrazilHospital São Lucas/Instituto do Cérebro (Inscer), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, BrazilHospital São Lucas/Instituto do Cérebro (Inscer), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, BrazilHospital São Lucas/Instituto do Cérebro (Inscer), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Avenida Ipiranga 6690, 90610-000 Porto Alegre, RS, BrazilPosterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, visual loss, and characteristic imaging pattern in brain MRI. The cause of PRES is not yet understood. We report a case of a 27-year-old woman that developed PRES after the use of FOLFOX 5 (oxaliplatin/5-Fluoracil/Leucovorin) chemotherapy for a colorectal cancer.http://dx.doi.org/10.1155/2013/306983 |
| spellingShingle | Luiz Carlos Porcello Marrone Bianca Fontana Marrone Tharick Ali Pascoal Lucas Porcello Schilling Ricardo Bernardi Soder Sheila Schuch Ferreira Giovani Gadonski Jaderson Costa da Costa Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy Case Reports in Oncological Medicine |
| title | Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy |
| title_full | Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy |
| title_fullStr | Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy |
| title_full_unstemmed | Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy |
| title_short | Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy |
| title_sort | posterior reversible encephalopathy syndrome associated with folfox chemotherapy |
| url | http://dx.doi.org/10.1155/2013/306983 |
| work_keys_str_mv | AT luizcarlosporcellomarrone posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy AT biancafontanamarrone posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy AT tharickalipascoal posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy AT lucasporcelloschilling posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy AT ricardobernardisoder posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy AT sheilaschuchferreira posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy AT giovanigadonski posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy AT jadersoncostadacosta posteriorreversibleencephalopathysyndromeassociatedwithfolfoxchemotherapy |